Breast cancer cells, when disseminated to other secondary organs such as the lungs, may stay in a dormant state for years, even decades. But the mechanisms that limit their expansion are not well ...

Patients with low-count chronic lymphocytic leukemia phenotype monoclonal B-cell lymphocytosis had a 1.86-fold greater risk ...

About 80% of people who have lung cancer have non-small-cell lung cancer. NSCLC usually spreads more slowly than small-cell lung cancers. Both cancers affect the lungs and have similar symptoms ...

Malignant cells down-regulate cell death by overexpressing a transcription factor called BCL6. “Our idea was to borrow a little bit of the activity of the kinase and drag it over to where BCL6 is ...

Some of the most widely used drugs today, including penicillin, were discovered through a process called phenotypic screening ...

A low white blood cell count is called leukopenia. A high white blood cell count is usually a sign of inflammation or infection, but it can be due to a blood-related cancer like leukemia or lymphoma.

Estrogens Play a Hidden Role in Cancers, Inhibiting a Key Immune Cell Sep. 27, 2024 — Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study ...

Modifying a protein that controls cell growth can reactivate dormant neural stem cells in fruit flies which could help ...

The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...

Oct. 7, 2024 — Researchers have discovered a natural immune mechanism in mice that stops escaped cancer cells from developing into tumors elsewhere in the ... Drug Improves Effectiveness of ...

Technology Networks caught up with Dr. Anne Carpenter at ELRIG Drug Discovery 2024 to learn more about the Cell Painting ...